HomeOpen Access NewsVaccinations

Vaccinations

Subscribe to Updates

Scientists reveal new vaccine for recurring yeast infections

Women's Health
University of Georgia researchers have successfully created a vaccine that protects and treats vaginal yeast infections in mice.

Scientists say Pfizer third dose decreases COVID death risk by 81%

Health & Social Care
According to a real-world study involving over 700,000 people, a Pfizer third dose can decrease COVID death risk by as much as 81%.

Are you eligible for the COVID-19 booster jab?

Health & Social Care
Find out everything you need to know about the UK Government's COVID-19 vaccination programme as the NHS begins to rollout booster jabs.

Document leak finds “Plan B” could cost UK economy £18 billion

Government
According to leaked documents, the UK Government is reluctant to use "Plan B" because COVID restrictions may cost the economy up to £18 billion.

Third of leukaemia patients show no COVID-19 antibody response

Cancer Research
According to a new study, a third of leukaemia patients fail to generate an antibody response following two COVID-19 vaccine doses.

UK creates deal for 480,000 doses of Merck COVID pill

Health & Social Care
The Merck COVID pill, molnupiravir, cuts risk of death by 50% - now, the UK have secured 480,000 doses for late 2021.

Risk of pregnancy loss not associated with COVID-19 vaccines

Women's Health
According to a new study, there is no risk of pregnancy loss associated with COVID-19 vaccinations.

Scientists find vaccinated teens 90% less likely to catch COVID

Health & Social Care
The real-world study finds that fully vaccinated teenagers are 90% less likely to catch COVID, according to an analysis of over 90,000 people.

MPs say UK Test and Trace system “ultimately failed” to stop deaths

Government
The 150-page Health and Social Committee report says the UK Government "ultimately failed" to establish a working Test and Trace system - which led to thousands of COVID deaths.

First malaria vaccine offers “glimmer of hope” to millions

Diseases & Conditions
The World Health Organisation has recently authorised a malaria vaccine, RTS,S/AS01, which has been successful in pilot schemes launched in 2019.

Merck “COVID pill” sold at forty-times what it costs to make

Research & Innovation
The "COVID pill" by Merck, found to halve virus hospitalisation and death rates, will be sold in the US at $712 per treatment - while costing $17.74 to produce.

The COVID insight of Molecular and Cellular Biosciences

Research & Innovation
We reflect on the work of the Molecular and Cellular Biosciences division (MCB), especially in context of the “complex biological web” of a global pandemic.

Study finds Pfizer vaccine works at 90% efficacy for six months

Research & Innovation
The study, published in The Lancet, finds that two doses of the Pfizer vaccine are 90% efficient for six months - decreasing to 47% after that time period.

Scientists create experimental vaccine for rheumatoid arthritis

Research & Innovation
The scientists found that "rheumatoid arthritis totally disappeared" in animals that were given the vaccine - creating hope for a functional vaccine.

Study says 0.0006% chance of myocarditis as COVID vaccine side effect

Research & Innovation
According to a study with 2,392,924 participants, acute myocarditis is an extremely rare side effect of the COVID vaccine - at 0.0006% likelihood.

Merck says “COVID pill” can decrease risk of death by 50%

Research & Innovation
Pharmaceutical company, Merck, have a "COVID pill" at Phase 3 clinical trial - which seems to decrease risk of death by 50%.

WHO recommends antibody treatment for immunocompromised people

Research & Innovation
The World Health Organisation, based on a study in The BMJ, finds that combining two antibody treatments could help immunocompromised people.
1...8910...22Page 9 of 22

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders

Visit Article Archive
Open Access Government

Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.

Follow Us

Resources

Quick Links

Legal & Marketing

As a Crossref Sponsored Member we are able to connect your content with a global network of online scholarly research, currently over 20,000 other organizational members from 160 countries. Crossref drive metadata exchange and support nearly 2 billion monthly API queries, facilitating global research communication.

© Adjacent Digital Politics Ltd